Status:
COMPLETED
The Effect of Enalapril, Losartan or Not Antihypertensive on the Oxidative Status in Renal Transplant Recipients
Lead Sponsor:
Unidad de Investigacion Medica en Enfermedades Renales
Conditions:
Oxidative Stress
Eligibility:
All Genders
18-65 years
Phase:
PHASE2
Brief Summary
The clinical and biochemical improvement observed in kidney transplant (RT) recipients is remarkable. The correct functioning of the allograft depends on various factors such as the donor's age, the a...
Detailed Description
An open, randomized clinical trial is proposed with a control group. It is carried out in the Transplant Division of the High Specialty Medical Unit of the Hospital de Especialidades, Centro Médico Na...
Eligibility Criteria
Inclusion
- Renal trasplant, from a living related donor (DVR) or living unrelated donor (DVNoR)
- Who agreed to participate and signed the Letter of Consent under Information.
Exclusion
- Patients who received an RT from a deceased donor,
- With donor \>55 years,
- With renal comorbidities at the time of the study (urolithiasis, infections, diabetes),
- With blood dyscrasias,
- Second transplantation,
- Those with treatment with non-steroidal anti-inflammatory drugs,
- Treatment with statins, spironolactone, pentoxifylline, patients
- With neurodegenerative processes
- Those who withdrew the Letter of Consent under Information
Key Trial Info
Start Date :
January 1 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 6 2022
Estimated Enrollment :
39 Patients enrolled
Trial Details
Trial ID
NCT05232370
Start Date
January 1 2022
End Date
January 6 2022
Last Update
February 9 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Enrique Rojas Campos
Guadalajara, Jalisco, Mexico, 44320